SEC Form 4 · accession 0001209191-17-060414
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Victor L Campbell
Officer — SVP
Period of report
Nov 8, 2017
Accepted (ET)
Nov 13, 2017 · 5:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 8, 2017 | S | 8,000 | $78.0019 | D | 34,478 | I | By AWC 2012 Trust (Spouse, Trustee) |
| Common Stock | holding | — | — | — | 127,275 | D | ||
| Common Stock | holding | — | — | — | 42,478 | I | By MNC 2012 Trust (Spouse, Trustee) | |
| Common Stock | holding | — | — | — | 33,196 | I | By Trust f/b/o AWC (Spouse, Trustee) | |
| Common Stock | holding | — | — | — | 33,196 | I | By Trust f/b/o MNC (Spouse, Trustee) | |
| Common Stock | holding | — | — | — | 65,629 | I | By Trust (Daughter, Trustee) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 to $78.0175, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.